首页> 外文期刊>Genetic testing and molecular biomarkers >Relationship of PTTG Expression with Tumor Invasiveness and Microvessel Density of Pituitary Adenomas: A Meta-Analysis
【24h】

Relationship of PTTG Expression with Tumor Invasiveness and Microvessel Density of Pituitary Adenomas: A Meta-Analysis

机译:PTTG表达与垂体腺瘤侵袭性和微血管密度的关系:Meta分析

获取原文
获取原文并翻译 | 示例
       

摘要

Aims: Many existing studies have demonstrated that pituitary tumor transforming gene (PTTG) expression may contribute to the development of pituitary adenomas (PAs), but individually published studies showed inconclusive results. This meta-analysis aimed to derive a more precise estimation of the relationships of PTTG expression with tumor invasiveness and microvessel density of pituitary adenomas. Methods: We searched CISCOM, CINAHL, Web of Science, PubMed, Google Scholar, EBSCO, Cochrane Library, and CBM databases from inception through September 1st, 2013. Meta-analysis was performed using the STATA 12.0 software. The crude odds ratio (OR) with 95% confidence interval (CI) was calculated. Results: Fifteen clinical cohort studies were included with a total of 752 pituitary adenoma patients. The meta-analysis results revealed that patients with invasive pituitary adenomas had higher positive expression of PTTG than those of noninvasive patients (OR=6.68, 95% CI=3.72-11.99, p<0.001). We also found a significant difference in the microvessel density between invasive and noninvasive patients (OR=1.81, 95% CI=0.39-3.23, p<0.001). No publication bias was detected in this meta-analysis (all p>0.05). Conclusion: The present meta-analysis suggests that PTTG expression may be associated with tumor invasiveness and microvessel density of pituitary adenomas. Thus, detection of PTTG expression may be useful for the prediction of malignancy degree in pituitary adenomas.
机译:目的:许多现有研究表明垂体肿瘤转化基因(PTTG)的表达可能有助于垂体腺瘤(PAs)的发展,但个别发表的研究结果尚无定论。这项荟萃分析旨在更精确地估算PTTG表达与垂体腺瘤的肿瘤浸润性和微血管密度之间的关系。方法:从开始到2013年9月1日,我们搜索了CISCOM,CINAHL,Web of Science,PubMed,Google Scholar,EBSCO,Cochrane Library和CBM数据库。使用STATA 12.0软件进行了荟萃分析。计算出具有95%置信区间(CI)的原始比值比(OR)。结果:共纳入15项临床队列研究,共752例垂体腺瘤患者。荟萃分析结果显示,侵袭性垂体腺瘤患者PTTG的阳性表达率高于非侵袭性垂体腺瘤(OR = 6.68,95%CI = 3.72-11.99,p <0.001)。我们还发现有创和无创患者的微血管密度存在显着差异(OR = 1.81,95%CI = 0.39-3.23,p <0.001)。在该荟萃分析中未发现任何发表偏倚(所有p> 0.05)。结论:本荟萃分析提示PTTG的表达可能与垂体腺瘤的侵袭性和微血管密度有关。因此,PTTG表达的检测对于垂体腺瘤的恶性程度的预测可能是有用的。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2014年第4期|279-285|共7页
  • 作者单位

    Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;

    Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, People's Republic of China;

    Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;

    Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;

    Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;

    Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;

    Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University, Shenyang, People's Republic of China;

    Molecular Oncology Department of Cancer Research Institution The First Hospital of China Medical University Nanjing Street No. 155 Heping District Shenyang 110001 People's Republic of China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:16:38

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号